The Pharmacology and Toxicology category covers a wide range of topics and this section strives to reflect that diversity. The section will emphasize original work and mini reviews that elucidate drug action and underlying mechanisms, new druggable targets, or unusual drug responses (e.g., due to polymorphisms and drug interactions), which contribute significant knowledge to pharmacology or toxicology. Submissions are expected to meet the standards of pharmacological and/or toxicological investigation. For example, manuscripts should include dose-response analysis, rather than using a single dose, and seek to demonstrate cause and effect relationships, rather than only presenting correlational findings. Appropriate control groups, such as drug vehicle-treated and drug-exposed normal groups, should be included. While manuscripts in all areas of pharmacology and toxicology are welcomed, studies on herbal medicines or plant extracts with unknown components or mixtures of active ingredients are generally not appropriate unless exceptional new activity has been discovered. Manuscripts reporting a known drug action on previously unstudied cells or tissue are generally also not appropriate without strong justification of the importance of the study.

Associate Editor

Santosh Kumar, University of Tennessee Health Science Center

Review Editors

Matthias Barton, MD, University of Zurich, Switzerland

Guzel Bikbova, MD/PhD, Chiba University, Japan

Pawel Brzuzan, PhD, University of Warmia and Mazury in Olsztyn, Poland

Laetitia Dou, PhD, Aix-Marseille Universite, France

Jianxiong Jiang, PhD, University of Tennessee Health Science Center, USA

Youngmi Jung, PhD, Pusan National University, Korea

Li-Fu Li, MD/PhD, Chang Gung Memorial Hospital and Chang Gung University, Taiwan

Samuel Gnana Prakash Vincent, PhD, Manonmaniam Sundaranar University, India

Jonathan Henry Shannahan, PhD, Purdue University, USA

Martin Sterba, PhD, Charles University Faculty of Medicine in Hradec Kralove,Czech Republic

Manish K. Tripathi, University of Texas Rio Grande Valley

Chaowu Xiao, PhD, Health Canada, Canada

Wuxiang Xie, PhD, Peking University Clinical Research Institute, China

Qihe Xu, MD/PhD, Kings College London, UK

Navigation group